Literature DB >> 11300438

Risk of acute first myocardial infarction and use of nicotine patches in a general population.

S E Kimmel1, J A Berlin, C Miles, J Jaskowiak, J L Carson, B L Strom.   

Abstract

OBJECTIVES: To determine if nicotine patches, both as prescribed and used over-the-counter, increase the risk of first myocardial infarction (MI).
BACKGROUND: Although nicotine patches improve smoking cessation rates, case reports have raised the hypothesis that they may increase the risk of MI.
METHODS: A population-based case-control study among 68 hospitals in an eight-county region surrounding Philadelphia was performed to determine if nicotine patches increase the risk of first MI. Cases were smokers (current or within the prior year) admitted to all hospitals in the region with a first MI. Controls were smokers (current or within the prior year) without prior MI selected from the same region using random-digit dialing. Data were collected by telephone interviews and chart reviews. The study had 80% power to detect an odds ratio (OR) of 2.5.
RESULTS: A total of 653 cases and 2,990 controls were interviewed. There was no association between nicotine patches and MI (OR 0.46; 95% CI: 0.09, 1.47), and the confidence interval (CI) excluded an effect from nicotine patches equal to that from cigarette smoking itself (OR < 2.5). Among those who abstained from smoking, the OR for use of nicotine patches was 0.25 (95% CI: 0.01, 1.67); among those who smoked concomitantly, the OR for patch use was 0.83 (95% CI: 0.09, 3.81). Adjustment for confounding did not alter the study's findings (OR adjusted for confounders that could mask a harmful effect of patches: 0.70; 95% CI: 0.20, 2.46).
CONCLUSIONS: Nicotine patches, as used in actual practice, do not appear to be associated with an increased risk of MI.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11300438     DOI: 10.1016/s0735-1097(01)01124-x

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  13 in total

1.  Current use of selective serotonin reuptake inhibitors and risk of acute myocardial infarction.

Authors:  Raymond G Schlienger; Lorenz M Fischer; Hershel Jick; Christoph R Meier
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

2.  Estimating the risks and benefits of nicotine replacement therapy for smoking cessation in the United States.

Authors:  Benjamin J Apelberg; Georgiana Onicescu; Erika Avila-Tang; Jonathan M Samet
Journal:  Am J Public Health       Date:  2009-12-17       Impact factor: 9.308

Review 3.  Cardiovascular adverse events associated with smoking-cessation pharmacotherapies.

Authors:  Abhishek Sharma; Saurabh Thakar; Carl J Lavie; Jalaj Garg; Parasuram Krishnamoorthy; Ondrej Sochor; Armin Arbab-Zadeh; Edgar Lichstein
Journal:  Curr Cardiol Rep       Date:  2015-01       Impact factor: 2.931

Review 4.  Current and emerging treatment approaches for tobacco dependence.

Authors:  K Michael Cummings; Martin Mahoney
Journal:  Curr Oncol Rep       Date:  2006-11       Impact factor: 5.075

Review 5.  Tailoring nicotine replacement therapy: rationale and potential approaches.

Authors:  Jennifer B McClure; Gary E Swan
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

6.  A naturalistic cohort study on effectiveness, safety and usage pattern of an over-the-counter nicotine patch. Cohort study on smoking cessation.

Authors:  Joerg Hasford; Karl Olov Fagerstrom; Knut-Olav Haustein
Journal:  Eur J Clin Pharmacol       Date:  2003-07-25       Impact factor: 2.953

Review 7.  Tobacco dependence and withdrawal: science base, challenges and opportunities for pharmacotherapy.

Authors:  Jack E Henningfield; Saul Shiffman; Stuart G Ferguson; Ellen R Gritz
Journal:  Pharmacol Ther       Date:  2009-04-08       Impact factor: 12.310

8.  Very low nicotine content cigarettes and potential consequences on cardiovascular disease.

Authors:  Danielle L Joel; Rachel L Denlinger; Sarah S Dermody; Dorothy K Hatsukami; Neal L Benowitz; Eric C Donny
Journal:  Curr Cardiovasc Risk Rep       Date:  2012-09-01

Review 9.  Cardiovascular effects of pharmacologic therapies for smoking cessation.

Authors:  Diana M Sobieraj; William B White; William L Baker
Journal:  J Am Soc Hypertens       Date:  2012-12-21

Review 10.  Electronic cigarettes for smoking cessation.

Authors:  Christopher Bullen
Journal:  Curr Cardiol Rep       Date:  2014-11       Impact factor: 2.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.